Mariola Fotin-Mleczek
Directeur Technique/Scientifique/R&D chez CureVac SE
Postes actifs de Mariola Fotin-Mleczek
Sociétés | Poste | Début | Fin |
---|---|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Directeur Technique/Scientifique/R&D | 01/01/2013 | - |
Historique de carrière de Mariola Fotin-Mleczek
Anciens postes connus de Mariola Fotin-Mleczek
Sociétés | Poste | Début | Fin |
---|---|---|---|
CUREVAC N.V. | Directeur Technique/Scientifique/R&D | 01/10/2018 | 31/01/2022 |
Statistiques
Internationale
Allemagne | 3 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 2 |
Sectorielle
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
CUREVAC N.V. | Health Technology |
Entreprise privées | 1 |
---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
- Bourse
- Insiders
- Mariola Fotin-Mleczek
- Expérience